Hyderabad (Telangana) [India], January 12 (ANI): Dr Reddy's Laboratories has said that independent Data and Safety Monitoring Board (DSMB) reviewed the safety data from phase two clinical trial of Russia's Covid-19 vaccine Sputnik V and recommended phase three recruitment along with continui
Hyderabad (Telangana) [India], January 11 (ANI): The Russian made Covid-19 vaccine Sputnik V has met the primary endpoint of safety in the phase-2 clinical trials in India and has been recommended to continue the clinical trial without any modifications, according to an official statement.
Hyderabad (Telangana) [India], January 7 (ANI): The Bharat Biotech International Limited on Thursday announced the successful completion of volunteer enrolment for phase-3 clinical trials of its indigenously manufactured COVID-19 vaccine 'Covaxin.'
New Delhi [India], January 6 (ANI): The Delhi High Court on Wednesday asked the AAP-led government to file its response over a plea seeking direction to ensure the immediate implementation of the Health Bill 2019 of the Government of Delhi or the Clinical Establishment Act 2010.
Goa [India], January 5 (ANI): Mumbai City FC extended their unbeaten run in the Indian Super League (ISL) season 7 with a comfortable 3-1 win over Bengaluru FC (BFC) at the Fatorda Stadium here on Tuesday.
New Delhi [India], January 5 (ANI): The Indian Council of Medical Research (ICMR) director Dr Balram Bhargava on Tuesday said that in a pandemic situation, restricted emergency use of the vaccine is considered based on phase 2 safety and immunogenicity clinical trial data while phase thre
New Delhi [India], January 4 (ANI): Coming down heavily on critics expressing doubts about the Bharat Biotech's indigenously developed coronavirus vaccine COVAXIN, the Hyderabad-based biotech major's managing director Dr Krishna Ella on Monday slammed the critics for targeting Indian clinica
New Delhi [India], January 4 (ANI): The drug regulatory body Drugs Controller General of India (DCGI) has approved Ahmedabad based drug firm Zydus Cadila to initiate Phase III clinical trials of its Covid-19 vaccine ZyCoV-D.
New Delhi [India], January 3 (ANI): Drugs Controller General of India (DCGI) on Sunday said the permission given to Bharat Biotech's COVAXIN is "for restricted use in an emergency situation" and it is given in "public interest as an abundant precaution" as the vaccine is still in clinical tr
Birmingham [UK], January 3 (ANI): A recent study has determined that Covid-19 patients might be helpful for clinicians to better understand how the unknown SARS-CoV-2 virus acts.
New Delhi [India], January 3 (ANI): Hours after Drugs Controller General of India (DCGI) approved restricted use in an emergency situation to Bharat Biotech's COVID-19 vaccine, Indian Council of Medical Research (ICMR) on Sunday said data generated through pre-clinical studies and various ph
Bangkok [Thailand], January 3 (ANI/Sputnik): Thailand has identified its first four cases of the new coronavirus strain that originated in the United Kingdom, the Thai PBS reported Sunday, citing the chief of the Center of Excellence in Clinical Virology at Chulalongkorn University, Yong Poo